High time to omit oxygen therapy in ST elevation myocardial infarction

Research output: Contribution to journalDebate/Note/Editorial


Supplemental oxygen (O2) therapy in patients with chest pain has been a cornerstone in the treatment of suspected myocardial infarction (MI). Recent randomized controlled trials have, however, shown that supplemental O2 therapy has no positive nor negative effects on cardiovascular functions, mortality, morbidity or pain in normoxic patients with suspected MI and foremost patients with ST Elevation Myocardial Infarction (STEMI). O2 therapy in normoxic STEMI patients should therefore be omitted. More studies are needed in discussing hemodynamically unstable STEMI patients, as well as patients with non-STEMI, unstable angina and other emergency conditions.


External organisations
  • Skåne University Hospital
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Physiology
  • Clinical Medicine


  • Oxygen, Oxygen Therapy, Myocardial Infarction, Physiology, STEMI, ST Elevation Myocardial Infarction
Original languageEnglish
Article number35
JournalBMC Emergency Medicine
Publication statusPublished - 2018 Oct 19
Publication categoryResearch

Total downloads

No data available

Related research output

Ardavan Khoshnood, Marcus Carlsson, Mahin Akbarzadeh, Pallonji Bhiladvala, Anders Roijer, David Nordlund, Peter Höglund, David Zughaft, Lizbet Todorova, Arash Mokhtari, Håkan Arheden, David Erlinge & Ulf Ekelund, 2018, In : European Journal of Emergency Medicine. 25, 2, p. 78-84 7 p.

Research output: Contribution to journalArticle

Ardavan Khoshnood, Mahin Akbarzadeh Mameghanilar, Anders Roijer, Carl Meurling, Marcus Carlsson, Pallonji Bhiladvala, Peter Höglund, David Sparv, Lizbet Todorova, Arash Mokhtari, David Erlinge & Ulf Ekelund, 2017, In : Echocardiography. 34, 8, p. 1130-1137 8 p.

Research output: Contribution to journalArticle

View all (4)

Related projects

View all (1)